{"id":4835,"date":"2012-04-27T15:34:00","date_gmt":"2012-04-27T12:34:00","guid":{"rendered":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2026\/01\/19\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/"},"modified":"2026-01-19T11:09:29","modified_gmt":"2026-01-19T08:09:29","slug":"sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi","status":"publish","type":"post","link":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/","title":{"rendered":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130"},"content":{"rendered":"<div style=\"padding-bottom: 100px; margin: auto; width: 90%; display: flex; justify-content: center; flex-direction: column;\">\n<div style=\"margin: 0cm 0cm 10pt\">\n <strong>SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (<span style=\"color: red\">MOR VE TURUNCU RE\u00c7ETELER<\/span>)<\/strong>\n<\/div>\n<div style=\"margin: 0cm 0cm 10pt\">\n SUT \u00e7al\u0131\u015fma Komisyonumuzun bundan sonraki duyurular\u0131nda, t\u00fcm maddelerini yay\u0131nlama yerine en \u00e7ok kar\u015f\u0131la\u015f\u0131lan ve probleme neden olan maddeler \u00fczerinde \u00e7al\u0131\u015fmalar\u0131n\u0131 yapacakt\u0131r . Bu \u00e7al\u0131\u015fmalar Odam\u0131z B\u00fcnyesindeki SUT Komisyonu ile SGK Eczac\u0131lar\u0131 taraf\u0131ndan yap\u0131lmaktad\u0131r. Bir sonraki duyurumuz&nbsp;, Toz mamalar\u0131n dozlar\u0131n\u0131n hesaplanmas\u0131, mamalar\u0131n muafiyet durumlar\u0131, ICD 10 Kodlar\u0131 ve Te\u015fhis Kodlar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmalar\u0131 \u00f6rneklemeli \u015feklinde olacakt\u0131r.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong><span style=\"color: red\">6.2.41. Parenteral Demir Preparatlar\u0131 Kullan\u0131m \u0130lkeleri: <\/span>(<em>Venofer, \u0130nferose&nbsp;amp.<\/em>) <\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>*<\/strong>Uzman Hekim taraf\u0131ndan d\u00fczenlenen raporuna dayan\u0131larak T\u00fcm Hekimlerce Re\u00e7ete edilir. Sadece a\u015fa\u011f\u0131daki durumlara \u00f6denir. <span style=\"background: yellow\">Bu tan\u0131lar\u0131n d\u0131\u015f\u0131nda bedeli \u00f6denmez.<\/span>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u0130ntestinal malabsorbsiyon sendromlar\u0131<\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>2-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kronik inflamatuvar ba\u011f\u0131rsak hastal\u0131klar\u0131 <\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>3-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aktif GIS kanamas\u0131 olan hastalar<\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>4-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemodiyaliz hastalar\u0131<\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>5-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total ve subtotal gastrektomili hastalar <\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong>6-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Atrofik gastritli hastalar<\/strong>\n<\/div>\n<div style=\"margin: 0cm 0cm 10pt\">\n <strong>7-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oral demir al\u0131m\u0131n\u0131 tolere edemeyen hamileler<\/p>\n<p> <span style=\"background-color: rgb(0, 255, 0); \">*Kronik B\u00f6brek Hastal\u0131klar\u0131 ,Organ ve Doku Naklinden muaf di\u011fer tan\u0131lardan muaf &nbsp;de\u011fildir.<\/span><br type=\"_moz\"> <\/strong>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong><span style=\"color: red\">6.2.27.A- Fakt\u00f6rler : &nbsp;<\/span>*Fakt\u00f6r d\u00fczeyi % 1\u2019in \u00fczerinde olan Hastalar\u0131n raporlar\u0131nda ayda \u00fc\u00e7ten fazla kanamas\u0131 oldu\u011fu belirtilmeli ve Profilaktik oldu\u011fu belirtilmelidir. <\/strong>Hemofili Uzman\u0131n\u0131n yer ald\u0131\u011f\u0131 Sa\u011fl\u0131k Kurulu raporuyla, Hemofili uzman\u0131n\u0131n olmad\u0131\u011f\u0131 hastanelerde ise sa\u011fl\u0131k kurul raporu \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan da d\u00fczenlenebilir.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n *Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda olan ve bu d\u00fczeyi raporunda belirtilen hastalar i\u00e7in ise haftal\u0131k 4500 \u00fcniteyi ge\u00e7meyecek \u015fekilde kar\u015f\u0131lanmal\u0131d\u0131r.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n &nbsp;* Hemofili hastalar\u0131n\u0131n fakt\u00f6r re\u00e7eteleri ve di\u011fer kan \u00fcr\u00fcn\u00fc re\u00e7eteleri d\u00f6rt n\u00fcshal\u0131 olacak, re\u00e7etelerin birinci n\u00fcshas\u0131 eczaneler taraf\u0131ndan \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fc\u011f\u00fcne, ikinci n\u00fcshas\u0131 Kuruma g\u00f6nderilecek, \u00fc\u00e7\u00fcnc\u00fc n\u00fcsha eczanede, d\u00f6rd\u00fcnc\u00fc n\u00fcsha ise karnede kalacakt\u0131r.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n * Kan \u00fcr\u00fcn\u00fc veren eczaneler, re\u00e7etelerin ilk n\u00fcshas\u0131 ile birlikte re\u00e7ete bilgilerini de i\u00e7eren \u201cHemofili Re\u00e7ete Formunu\u201d ve \u201cKan \u00dcr\u00fcnleri Re\u00e7ete Formunu\u201d doldurarak her ay \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fcklerine g\u00f6nderecektir.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n * Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n *Re\u00e7ete : <span style=\"text-decoration: underline;\">Hematoloji Uzman\u0131, \u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131<\/span> veya <span style=\"text-decoration: underline;\">\u00c7ocuk Hastal\u0131klar\u0131 Uzman\u0131<\/span> taraf\u0131ndan re\u00e7ete edilmelidir. Mevcut Fakt\u00f6r D\u00fczeyi, Hedef Fakt\u00f6r D\u00fczeyi ve Hastan\u0131n kilosu Hastaya verilen Taki karnelerindeki re\u00e7etelerde belirtilecektir.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n *Medulla Provizyon Sistemine Giri\u015f : Fakt\u00f6r VIII 500 \u00dc 36 Adet \u015feklinde yaz\u0131lan re\u00e7etenin Sisteme&nbsp;Giri\u015fi: Fakt\u00f6r VIII 500 1X9 Hafta veya 7 G\u00fcn yaz\u0131lacat\u0131r.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong><span style=\"color: red\">6.2.27.B- Anti Rh kullan\u0131m ilkeleri : <\/span>*Re\u00e7etede Anne ve Baba Kan gruplar\u0131 belirtilmi\u015f olacak. <span style=\"color: red\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/strong>(1) Do\u011fum sonu, d\u00fc\u015f\u00fck veya k\u00fcretaj sonras\u0131 ve antenatal kullan\u0131mda; anne ve baban\u0131n kan gruplar\u0131n\u0131n hasta dosyas\u0131nda yer almas\u0131 gerekmektedir.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n (2) D\u00fc\u015f\u00fck doz anti <span style=\"background: aqua\">Rh (600IU)<\/span> preperatlar\u0131; yaln\u0131zca <span style=\"background: aqua\">d\u00fc\u015f\u00fck, k\u00fcretaj ve gebeli\u011fin 28.<\/span> haftas\u0131nda kullan\u0131labilecektir\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n (3) Idiopatik (\u0130mm\u00fcn) trombositopenide <span style=\"background: aqua\">(ITP)<\/span>; \u0130ntraven\u00f6z formu <span style=\"text-decoration: underline;\">Rh pozitif ve splenektomisiz<\/span> hastalarda hematoloji uzman hekimince d\u00fczenlenen <span style=\"text-decoration: underline;\">doz ve kullan\u0131m s\u00fcresi belirtilen<\/span> uzman hekim raporuna dayan\u0131larak bu hekimlerce re\u00e7ete edilebilir.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong><span style=\"color: red\">6.2.27.\u00c7- Human Albumin Kullan\u0131m \u0130lkeleri : <\/span>*Uzman Hekim Raporuyla ve sadece Yatan Hastalarda \u00d6denir. <\/strong>Raporda alb\u00fcmin d\u00fczeyi 2.5g\/dl ve alt\u0131nda oldu\u011fu belirtilir ve T\u00fcm Uzman Hekimlerce en fazla <span style=\"background: red\">3 g\u00fcnl\u00fck tedavi<\/span> dozunda yaz\u0131labilir. Re\u00e7etelere Hastane taraf\u0131ndan \u201cEczanemizde Yoktur Yatan Hasta\u201d ka\u015fesi bas\u0131l\u0131p ba\u015fhekimlik onay\u0131 ile re\u00e7ete kar\u015f\u0131lan\u0131r. Plazmaferezde ve karaci\u011fer nakli yap\u0131lm\u0131\u015f hastalarda kan alb\u00fcmin d\u00fczeyi \u015fart\u0131 aranmaz.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <strong><span style=\"color: red\">6.2.12. \u0130mm\u00fcnglobulinlerin Kullan\u0131m \u0130lkeleri : <\/span><\/strong>&nbsp;Hepatit B \u0130mmunglobulinin,\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n &nbsp;*Raporunda Karaci\u011fer nakli oldu\u011fu belirtilecek.\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n &nbsp;*(Hbs Ag) pozitif oldu\u011fu belirtilecek\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n &nbsp;\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n &nbsp;\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n <span style=\"text-decoration: underline;\">KOM\u0130SYON \u00dcYELER\u0130<\/span>\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n Ecz.Mustafa KUTLUO\u011eLU\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n Ecz.C\u00fcneyt YAVUZ\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n Ecz.Servet KILI\u00c7\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n Ecz.M.Ali \u00dc\u00c7K\u00d6K\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n Ecz.M.Umut AKINCI\n<\/div>\n<div style=\"text-align: justify; line-height: 12pt; margin: 0cm 0cm 10pt\">\n Ecz.Mehmet F\u0130TK\u0130\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) SUT \u00e7al\u0131\u015fma Komisyonumuzun bundan sonraki duyurular\u0131nda, t\u00fcm maddelerini yay\u0131nlama yerine en \u00e7ok kar\u015f\u0131la\u015f\u0131lan ve probleme neden olan maddeler \u00fczerinde \u00e7al\u0131\u015fmalar\u0131n\u0131 yapacakt\u0131r . Bu \u00e7al\u0131\u015fmalar Odam\u0131z B\u00fcnyesindeki SUT Komisyonu ile SGK Eczac\u0131lar\u0131 taraf\u0131ndan yap\u0131lmaktad\u0131r. Bir sonraki duyurumuz&nbsp;, Toz mamalar\u0131n dozlar\u0131n\u0131n hesaplanmas\u0131, mamalar\u0131n muafiyet durumlar\u0131, ICD 10 Kodlar\u0131 ve Te\u015fhis Kodlar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmalar\u0131 \u00f6rneklemeli \u015feklinde olacakt\u0131r. 6.2.41. Parenteral Demir Preparatlar\u0131 Kullan\u0131m \u0130lkeleri: (Venofer, \u0130nferose&nbsp;amp.) *Uzman Hekim taraf\u0131ndan d\u00fczenlenen raporuna dayan\u0131larak T\u00fcm Hekimlerce Re\u00e7ete edilir. Sadece a\u015fa\u011f\u0131daki durumlara \u00f6denir. Bu tan\u0131lar\u0131n d\u0131\u015f\u0131nda bedeli \u00f6denmez. 1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u0130ntestinal malabsorbsiyon sendromlar\u0131 2-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kronik inflamatuvar ba\u011f\u0131rsak hastal\u0131klar\u0131 3-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aktif GIS kanamas\u0131 olan hastalar 4-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemodiyaliz hastalar\u0131 5-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total ve subtotal gastrektomili hastalar 6-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Atrofik gastritli hastalar 7-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oral demir al\u0131m\u0131n\u0131 tolere edemeyen hamileler *Kronik B\u00f6brek Hastal\u0131klar\u0131 ,Organ ve Doku Naklinden muaf di\u011fer tan\u0131lardan muaf &nbsp;de\u011fildir. 6.2.27.A- Fakt\u00f6rler : &nbsp;*Fakt\u00f6r d\u00fczeyi % 1\u2019in \u00fczerinde olan Hastalar\u0131n raporlar\u0131nda ayda \u00fc\u00e7ten fazla kanamas\u0131 oldu\u011fu belirtilmeli ve Profilaktik oldu\u011fu belirtilmelidir. Hemofili Uzman\u0131n\u0131n yer ald\u0131\u011f\u0131 Sa\u011fl\u0131k Kurulu raporuyla, Hemofili uzman\u0131n\u0131n olmad\u0131\u011f\u0131 hastanelerde ise sa\u011fl\u0131k kurul raporu \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan da d\u00fczenlenebilir. *Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda olan ve bu d\u00fczeyi raporunda belirtilen hastalar i\u00e7in ise haftal\u0131k 4500 \u00fcniteyi ge\u00e7meyecek \u015fekilde kar\u015f\u0131lanmal\u0131d\u0131r. &nbsp;* Hemofili hastalar\u0131n\u0131n fakt\u00f6r re\u00e7eteleri ve di\u011fer kan \u00fcr\u00fcn\u00fc re\u00e7eteleri d\u00f6rt n\u00fcshal\u0131 olacak, re\u00e7etelerin birinci n\u00fcshas\u0131 eczaneler taraf\u0131ndan \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fc\u011f\u00fcne, ikinci n\u00fcshas\u0131 Kuruma g\u00f6nderilecek, \u00fc\u00e7\u00fcnc\u00fc n\u00fcsha eczanede, d\u00f6rd\u00fcnc\u00fc n\u00fcsha ise karnede kalacakt\u0131r. * Kan \u00fcr\u00fcn\u00fc veren eczaneler, re\u00e7etelerin ilk n\u00fcshas\u0131 ile birlikte re\u00e7ete bilgilerini de i\u00e7eren \u201cHemofili Re\u00e7ete Formunu\u201d ve \u201cKan \u00dcr\u00fcnleri Re\u00e7ete Formunu\u201d doldurarak her ay \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fcklerine g\u00f6nderecektir. * Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir. *Re\u00e7ete : Hematoloji Uzman\u0131, \u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 veya \u00c7ocuk Hastal\u0131klar\u0131 Uzman\u0131 taraf\u0131ndan re\u00e7ete edilmelidir. Mevcut Fakt\u00f6r D\u00fczeyi, Hedef Fakt\u00f6r D\u00fczeyi ve Hastan\u0131n kilosu Hastaya verilen Taki karnelerindeki re\u00e7etelerde belirtilecektir. *Medulla Provizyon Sistemine Giri\u015f : Fakt\u00f6r VIII 500 \u00dc 36 Adet \u015feklinde yaz\u0131lan re\u00e7etenin Sisteme&nbsp;Giri\u015fi: Fakt\u00f6r VIII 500 1X9 Hafta veya 7 G\u00fcn yaz\u0131lacat\u0131r. 6.2.27.B- Anti Rh kullan\u0131m ilkeleri : *Re\u00e7etede Anne ve Baba Kan gruplar\u0131 belirtilmi\u015f olacak. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Do\u011fum sonu, d\u00fc\u015f\u00fck veya k\u00fcretaj sonras\u0131 ve antenatal kullan\u0131mda; anne ve baban\u0131n kan gruplar\u0131n\u0131n hasta dosyas\u0131nda yer almas\u0131 gerekmektedir. (2) D\u00fc\u015f\u00fck doz anti Rh (600IU) preperatlar\u0131; yaln\u0131zca d\u00fc\u015f\u00fck, k\u00fcretaj ve gebeli\u011fin 28. haftas\u0131nda kullan\u0131labilecektir (3) Idiopatik (\u0130mm\u00fcn) trombositopenide (ITP); \u0130ntraven\u00f6z formu Rh pozitif ve splenektomisiz hastalarda hematoloji uzman hekimince d\u00fczenlenen doz ve kullan\u0131m s\u00fcresi belirtilen uzman hekim raporuna dayan\u0131larak bu hekimlerce re\u00e7ete edilebilir. 6.2.27.\u00c7- Human Albumin Kullan\u0131m \u0130lkeleri : *Uzman Hekim Raporuyla ve sadece Yatan Hastalarda \u00d6denir. Raporda alb\u00fcmin d\u00fczeyi 2.5g\/dl ve alt\u0131nda oldu\u011fu belirtilir ve T\u00fcm Uzman Hekimlerce en fazla 3 g\u00fcnl\u00fck tedavi dozunda yaz\u0131labilir. Re\u00e7etelere Hastane taraf\u0131ndan \u201cEczanemizde Yoktur Yatan Hasta\u201d ka\u015fesi bas\u0131l\u0131p ba\u015fhekimlik onay\u0131 ile re\u00e7ete kar\u015f\u0131lan\u0131r. Plazmaferezde ve karaci\u011fer nakli yap\u0131lm\u0131\u015f hastalarda kan alb\u00fcmin d\u00fczeyi \u015fart\u0131 aranmaz. 6.2.12. \u0130mm\u00fcnglobulinlerin Kullan\u0131m \u0130lkeleri : &nbsp;Hepatit B \u0130mmunglobulinin, &nbsp;*Raporunda Karaci\u011fer nakli oldu\u011fu belirtilecek. &nbsp;*(Hbs Ag) pozitif oldu\u011fu belirtilecek &nbsp; &nbsp; KOM\u0130SYON \u00dcYELER\u0130 Ecz.Mustafa KUTLUO\u011eLU Ecz.C\u00fcneyt YAVUZ Ecz.Servet KILI\u00c7 Ecz.M.Ali \u00dc\u00c7K\u00d6K Ecz.M.Umut AKINCI Ecz.Mehmet F\u0130TK\u0130<\/p>\n","protected":false},"author":4,"featured_media":191,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4835","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"og:description\" content=\"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) SUT \u00e7al\u0131\u015fma Komisyonumuzun bundan sonraki duyurular\u0131nda, t\u00fcm maddelerini yay\u0131nlama yerine en \u00e7ok kar\u015f\u0131la\u015f\u0131lan ve probleme neden olan maddeler \u00fczerinde \u00e7al\u0131\u015fmalar\u0131n\u0131 yapacakt\u0131r . Bu \u00e7al\u0131\u015fmalar Odam\u0131z B\u00fcnyesindeki SUT Komisyonu ile SGK Eczac\u0131lar\u0131 taraf\u0131ndan yap\u0131lmaktad\u0131r. Bir sonraki duyurumuz&nbsp;, Toz mamalar\u0131n dozlar\u0131n\u0131n hesaplanmas\u0131, mamalar\u0131n muafiyet durumlar\u0131, ICD 10 Kodlar\u0131 ve Te\u015fhis Kodlar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmalar\u0131 \u00f6rneklemeli \u015feklinde olacakt\u0131r. 6.2.41. Parenteral Demir Preparatlar\u0131 Kullan\u0131m \u0130lkeleri: (Venofer, \u0130nferose&nbsp;amp.) *Uzman Hekim taraf\u0131ndan d\u00fczenlenen raporuna dayan\u0131larak T\u00fcm Hekimlerce Re\u00e7ete edilir. Sadece a\u015fa\u011f\u0131daki durumlara \u00f6denir. Bu tan\u0131lar\u0131n d\u0131\u015f\u0131nda bedeli \u00f6denmez. 1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u0130ntestinal malabsorbsiyon sendromlar\u0131 2-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kronik inflamatuvar ba\u011f\u0131rsak hastal\u0131klar\u0131 3-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aktif GIS kanamas\u0131 olan hastalar 4-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemodiyaliz hastalar\u0131 5-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total ve subtotal gastrektomili hastalar 6-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Atrofik gastritli hastalar 7-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oral demir al\u0131m\u0131n\u0131 tolere edemeyen hamileler *Kronik B\u00f6brek Hastal\u0131klar\u0131 ,Organ ve Doku Naklinden muaf di\u011fer tan\u0131lardan muaf &nbsp;de\u011fildir. 6.2.27.A- Fakt\u00f6rler : &nbsp;*Fakt\u00f6r d\u00fczeyi % 1\u2019in \u00fczerinde olan Hastalar\u0131n raporlar\u0131nda ayda \u00fc\u00e7ten fazla kanamas\u0131 oldu\u011fu belirtilmeli ve Profilaktik oldu\u011fu belirtilmelidir. Hemofili Uzman\u0131n\u0131n yer ald\u0131\u011f\u0131 Sa\u011fl\u0131k Kurulu raporuyla, Hemofili uzman\u0131n\u0131n olmad\u0131\u011f\u0131 hastanelerde ise sa\u011fl\u0131k kurul raporu \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan da d\u00fczenlenebilir. *Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda olan ve bu d\u00fczeyi raporunda belirtilen hastalar i\u00e7in ise haftal\u0131k 4500 \u00fcniteyi ge\u00e7meyecek \u015fekilde kar\u015f\u0131lanmal\u0131d\u0131r. &nbsp;* Hemofili hastalar\u0131n\u0131n fakt\u00f6r re\u00e7eteleri ve di\u011fer kan \u00fcr\u00fcn\u00fc re\u00e7eteleri d\u00f6rt n\u00fcshal\u0131 olacak, re\u00e7etelerin birinci n\u00fcshas\u0131 eczaneler taraf\u0131ndan \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fc\u011f\u00fcne, ikinci n\u00fcshas\u0131 Kuruma g\u00f6nderilecek, \u00fc\u00e7\u00fcnc\u00fc n\u00fcsha eczanede, d\u00f6rd\u00fcnc\u00fc n\u00fcsha ise karnede kalacakt\u0131r. * Kan \u00fcr\u00fcn\u00fc veren eczaneler, re\u00e7etelerin ilk n\u00fcshas\u0131 ile birlikte re\u00e7ete bilgilerini de i\u00e7eren \u201cHemofili Re\u00e7ete Formunu\u201d ve \u201cKan \u00dcr\u00fcnleri Re\u00e7ete Formunu\u201d doldurarak her ay \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fcklerine g\u00f6nderecektir. * Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir. *Re\u00e7ete : Hematoloji Uzman\u0131, \u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 veya \u00c7ocuk Hastal\u0131klar\u0131 Uzman\u0131 taraf\u0131ndan re\u00e7ete edilmelidir. Mevcut Fakt\u00f6r D\u00fczeyi, Hedef Fakt\u00f6r D\u00fczeyi ve Hastan\u0131n kilosu Hastaya verilen Taki karnelerindeki re\u00e7etelerde belirtilecektir. *Medulla Provizyon Sistemine Giri\u015f : Fakt\u00f6r VIII 500 \u00dc 36 Adet \u015feklinde yaz\u0131lan re\u00e7etenin Sisteme&nbsp;Giri\u015fi: Fakt\u00f6r VIII 500 1X9 Hafta veya 7 G\u00fcn yaz\u0131lacat\u0131r. 6.2.27.B- Anti Rh kullan\u0131m ilkeleri : *Re\u00e7etede Anne ve Baba Kan gruplar\u0131 belirtilmi\u015f olacak. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Do\u011fum sonu, d\u00fc\u015f\u00fck veya k\u00fcretaj sonras\u0131 ve antenatal kullan\u0131mda; anne ve baban\u0131n kan gruplar\u0131n\u0131n hasta dosyas\u0131nda yer almas\u0131 gerekmektedir. (2) D\u00fc\u015f\u00fck doz anti Rh (600IU) preperatlar\u0131; yaln\u0131zca d\u00fc\u015f\u00fck, k\u00fcretaj ve gebeli\u011fin 28. haftas\u0131nda kullan\u0131labilecektir (3) Idiopatik (\u0130mm\u00fcn) trombositopenide (ITP); \u0130ntraven\u00f6z formu Rh pozitif ve splenektomisiz hastalarda hematoloji uzman hekimince d\u00fczenlenen doz ve kullan\u0131m s\u00fcresi belirtilen uzman hekim raporuna dayan\u0131larak bu hekimlerce re\u00e7ete edilebilir. 6.2.27.\u00c7- Human Albumin Kullan\u0131m \u0130lkeleri : *Uzman Hekim Raporuyla ve sadece Yatan Hastalarda \u00d6denir. Raporda alb\u00fcmin d\u00fczeyi 2.5g\/dl ve alt\u0131nda oldu\u011fu belirtilir ve T\u00fcm Uzman Hekimlerce en fazla 3 g\u00fcnl\u00fck tedavi dozunda yaz\u0131labilir. Re\u00e7etelere Hastane taraf\u0131ndan \u201cEczanemizde Yoktur Yatan Hasta\u201d ka\u015fesi bas\u0131l\u0131p ba\u015fhekimlik onay\u0131 ile re\u00e7ete kar\u015f\u0131lan\u0131r. Plazmaferezde ve karaci\u011fer nakli yap\u0131lm\u0131\u015f hastalarda kan alb\u00fcmin d\u00fczeyi \u015fart\u0131 aranmaz. 6.2.12. \u0130mm\u00fcnglobulinlerin Kullan\u0131m \u0130lkeleri : &nbsp;Hepatit B \u0130mmunglobulinin, &nbsp;*Raporunda Karaci\u011fer nakli oldu\u011fu belirtilecek. &nbsp;*(Hbs Ag) pozitif oldu\u011fu belirtilecek &nbsp; &nbsp; KOM\u0130SYON \u00dcYELER\u0130 Ecz.Mustafa KUTLUO\u011eLU Ecz.C\u00fcneyt YAVUZ Ecz.Servet KILI\u00c7 Ecz.M.Ali \u00dc\u00c7K\u00d6K Ecz.M.Umut AKINCI Ecz.Mehmet F\u0130TK\u0130\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/\" \/>\n<meta property=\"og:site_name\" content=\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"article:published_time\" content=\"2012-04-27T12:34:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T08:09:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Yeni Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yeni Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/\"},\"author\":{\"name\":\"Yeni Admin\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\"},\"headline\":\"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130\",\"datePublished\":\"2012-04-27T12:34:00+00:00\",\"dateModified\":\"2026-01-19T08:09:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/\"},\"wordCount\":775,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"articleSection\":[\"ODA\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/\",\"name\":\"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"datePublished\":\"2012-04-27T12:34:00+00:00\",\"dateModified\":\"2026-01-19T08:09:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"contentUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2012\\\/04\\\/27\\\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#website\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"contentUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"width\":635,\"height\":635,\"caption\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\",\"name\":\"Yeni Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"caption\":\"Yeni Admin\"},\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/author\\\/yeniadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/","og_locale":"tr_TR","og_type":"article","og_title":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","og_description":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) SUT \u00e7al\u0131\u015fma Komisyonumuzun bundan sonraki duyurular\u0131nda, t\u00fcm maddelerini yay\u0131nlama yerine en \u00e7ok kar\u015f\u0131la\u015f\u0131lan ve probleme neden olan maddeler \u00fczerinde \u00e7al\u0131\u015fmalar\u0131n\u0131 yapacakt\u0131r . Bu \u00e7al\u0131\u015fmalar Odam\u0131z B\u00fcnyesindeki SUT Komisyonu ile SGK Eczac\u0131lar\u0131 taraf\u0131ndan yap\u0131lmaktad\u0131r. Bir sonraki duyurumuz&nbsp;, Toz mamalar\u0131n dozlar\u0131n\u0131n hesaplanmas\u0131, mamalar\u0131n muafiyet durumlar\u0131, ICD 10 Kodlar\u0131 ve Te\u015fhis Kodlar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmalar\u0131 \u00f6rneklemeli \u015feklinde olacakt\u0131r. 6.2.41. Parenteral Demir Preparatlar\u0131 Kullan\u0131m \u0130lkeleri: (Venofer, \u0130nferose&nbsp;amp.) *Uzman Hekim taraf\u0131ndan d\u00fczenlenen raporuna dayan\u0131larak T\u00fcm Hekimlerce Re\u00e7ete edilir. Sadece a\u015fa\u011f\u0131daki durumlara \u00f6denir. Bu tan\u0131lar\u0131n d\u0131\u015f\u0131nda bedeli \u00f6denmez. 1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \u0130ntestinal malabsorbsiyon sendromlar\u0131 2-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kronik inflamatuvar ba\u011f\u0131rsak hastal\u0131klar\u0131 3-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aktif GIS kanamas\u0131 olan hastalar 4-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemodiyaliz hastalar\u0131 5-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total ve subtotal gastrektomili hastalar 6-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Atrofik gastritli hastalar 7-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oral demir al\u0131m\u0131n\u0131 tolere edemeyen hamileler *Kronik B\u00f6brek Hastal\u0131klar\u0131 ,Organ ve Doku Naklinden muaf di\u011fer tan\u0131lardan muaf &nbsp;de\u011fildir. 6.2.27.A- Fakt\u00f6rler : &nbsp;*Fakt\u00f6r d\u00fczeyi % 1\u2019in \u00fczerinde olan Hastalar\u0131n raporlar\u0131nda ayda \u00fc\u00e7ten fazla kanamas\u0131 oldu\u011fu belirtilmeli ve Profilaktik oldu\u011fu belirtilmelidir. Hemofili Uzman\u0131n\u0131n yer ald\u0131\u011f\u0131 Sa\u011fl\u0131k Kurulu raporuyla, Hemofili uzman\u0131n\u0131n olmad\u0131\u011f\u0131 hastanelerde ise sa\u011fl\u0131k kurul raporu \u00fc\u00e7 i\u00e7 hastal\u0131klar\u0131 ya da \u00fc\u00e7 \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimi taraf\u0131ndan da d\u00fczenlenebilir. *Fakt\u00f6r d\u00fczeyi %1 in alt\u0131nda olan ve bu d\u00fczeyi raporunda belirtilen hastalar i\u00e7in ise haftal\u0131k 4500 \u00fcniteyi ge\u00e7meyecek \u015fekilde kar\u015f\u0131lanmal\u0131d\u0131r. &nbsp;* Hemofili hastalar\u0131n\u0131n fakt\u00f6r re\u00e7eteleri ve di\u011fer kan \u00fcr\u00fcn\u00fc re\u00e7eteleri d\u00f6rt n\u00fcshal\u0131 olacak, re\u00e7etelerin birinci n\u00fcshas\u0131 eczaneler taraf\u0131ndan \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fc\u011f\u00fcne, ikinci n\u00fcshas\u0131 Kuruma g\u00f6nderilecek, \u00fc\u00e7\u00fcnc\u00fc n\u00fcsha eczanede, d\u00f6rd\u00fcnc\u00fc n\u00fcsha ise karnede kalacakt\u0131r. * Kan \u00fcr\u00fcn\u00fc veren eczaneler, re\u00e7etelerin ilk n\u00fcshas\u0131 ile birlikte re\u00e7ete bilgilerini de i\u00e7eren \u201cHemofili Re\u00e7ete Formunu\u201d ve \u201cKan \u00dcr\u00fcnleri Re\u00e7ete Formunu\u201d doldurarak her ay \u0130l Sa\u011fl\u0131k M\u00fcd\u00fcrl\u00fcklerine g\u00f6nderecektir. * Haftal\u0131k fakt\u00f6r kullan\u0131m\u0131n\u0131n 4500 \u00fcniteyi ge\u00e7mesi gerekti\u011fi durumlarda ayr\u0131ca bu durumu belirten yeni bir sa\u011fl\u0131k kurulu raporu d\u00fczenlenecektir. *Re\u00e7ete : Hematoloji Uzman\u0131, \u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 veya \u00c7ocuk Hastal\u0131klar\u0131 Uzman\u0131 taraf\u0131ndan re\u00e7ete edilmelidir. Mevcut Fakt\u00f6r D\u00fczeyi, Hedef Fakt\u00f6r D\u00fczeyi ve Hastan\u0131n kilosu Hastaya verilen Taki karnelerindeki re\u00e7etelerde belirtilecektir. *Medulla Provizyon Sistemine Giri\u015f : Fakt\u00f6r VIII 500 \u00dc 36 Adet \u015feklinde yaz\u0131lan re\u00e7etenin Sisteme&nbsp;Giri\u015fi: Fakt\u00f6r VIII 500 1X9 Hafta veya 7 G\u00fcn yaz\u0131lacat\u0131r. 6.2.27.B- Anti Rh kullan\u0131m ilkeleri : *Re\u00e7etede Anne ve Baba Kan gruplar\u0131 belirtilmi\u015f olacak. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Do\u011fum sonu, d\u00fc\u015f\u00fck veya k\u00fcretaj sonras\u0131 ve antenatal kullan\u0131mda; anne ve baban\u0131n kan gruplar\u0131n\u0131n hasta dosyas\u0131nda yer almas\u0131 gerekmektedir. (2) D\u00fc\u015f\u00fck doz anti Rh (600IU) preperatlar\u0131; yaln\u0131zca d\u00fc\u015f\u00fck, k\u00fcretaj ve gebeli\u011fin 28. haftas\u0131nda kullan\u0131labilecektir (3) Idiopatik (\u0130mm\u00fcn) trombositopenide (ITP); \u0130ntraven\u00f6z formu Rh pozitif ve splenektomisiz hastalarda hematoloji uzman hekimince d\u00fczenlenen doz ve kullan\u0131m s\u00fcresi belirtilen uzman hekim raporuna dayan\u0131larak bu hekimlerce re\u00e7ete edilebilir. 6.2.27.\u00c7- Human Albumin Kullan\u0131m \u0130lkeleri : *Uzman Hekim Raporuyla ve sadece Yatan Hastalarda \u00d6denir. Raporda alb\u00fcmin d\u00fczeyi 2.5g\/dl ve alt\u0131nda oldu\u011fu belirtilir ve T\u00fcm Uzman Hekimlerce en fazla 3 g\u00fcnl\u00fck tedavi dozunda yaz\u0131labilir. Re\u00e7etelere Hastane taraf\u0131ndan \u201cEczanemizde Yoktur Yatan Hasta\u201d ka\u015fesi bas\u0131l\u0131p ba\u015fhekimlik onay\u0131 ile re\u00e7ete kar\u015f\u0131lan\u0131r. Plazmaferezde ve karaci\u011fer nakli yap\u0131lm\u0131\u015f hastalarda kan alb\u00fcmin d\u00fczeyi \u015fart\u0131 aranmaz. 6.2.12. \u0130mm\u00fcnglobulinlerin Kullan\u0131m \u0130lkeleri : &nbsp;Hepatit B \u0130mmunglobulinin, &nbsp;*Raporunda Karaci\u011fer nakli oldu\u011fu belirtilecek. &nbsp;*(Hbs Ag) pozitif oldu\u011fu belirtilecek &nbsp; &nbsp; KOM\u0130SYON \u00dcYELER\u0130 Ecz.Mustafa KUTLUO\u011eLU Ecz.C\u00fcneyt YAVUZ Ecz.Servet KILI\u00c7 Ecz.M.Ali \u00dc\u00c7K\u00d6K Ecz.M.Umut AKINCI Ecz.Mehmet F\u0130TK\u0130","og_url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/","og_site_name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","article_published_time":"2012-04-27T12:34:00+00:00","article_modified_time":"2026-01-19T08:09:29+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","type":"image\/png"}],"author":"Yeni Admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Yeni Admin","Tahmini okuma s\u00fcresi":"4 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#article","isPartOf":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/"},"author":{"name":"Yeni Admin","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120"},"headline":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130","datePublished":"2012-04-27T12:34:00+00:00","dateModified":"2026-01-19T08:09:29+00:00","mainEntityOfPage":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/"},"wordCount":775,"commentCount":0,"publisher":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#primaryimage"},"thumbnailUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","articleSection":["ODA"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/","url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/","name":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130 - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","isPartOf":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#primaryimage"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#primaryimage"},"thumbnailUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","datePublished":"2012-04-27T12:34:00+00:00","dateModified":"2026-01-19T08:09:29+00:00","breadcrumb":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#primaryimage","url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","contentUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2012\/04\/27\/sut-komisyonu-calismasi-1-mor-ve-turuncu-receteler-revize-edildi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/sanliurfaeo.birodam.org.tr\/"},{"@type":"ListItem","position":2,"name":"SUT KOM\u0130SYONU \u00c7ALI\u015eMASI -1 (MOR VE TURUNCU RE\u00c7ETELER) REV\u0130ZE ED\u0130LD\u0130"}]},{"@type":"WebSite","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#website","url":"https:\/\/sanliurfaeo.birodam.org.tr\/","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","description":"","publisher":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sanliurfaeo.birodam.org.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","url":"https:\/\/sanliurfaeo.birodam.org.tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/logo\/image\/","url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","contentUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","width":635,"height":635,"caption":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120","name":"Yeni Admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","caption":"Yeni Admin"},"url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/author\/yeniadmin\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts\/4835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/comments?post=4835"}],"version-history":[{"count":0,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts\/4835\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/media?parent=4835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/categories?post=4835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/tags?post=4835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}